Company Profiles

driven by the PitchBook Platform

Galenea

Description

Developer of therapies designed to focus on synaptic transmission for the treatment of diseases of central nervous system. The company's therapies utilize new technology to identify small molecule synaptic modulators that evaluates drug effects in isolated brain regions from normal and diseased rodents, enabling physicians to predict human responses.

2003

Founded

OOB

Status

51-200

Employees

Liquidation

Latest Deal Type

$6M

Total Amount Raised

Description

Developer of therapies designed to focus on synaptic transmission for the treatment of diseases of central nervous system. The company's therapies utilize new technology to identify small molecule synaptic modulators that evaluates drug effects in isolated brain regions from normal and diseased rodents, enabling physicians to predict human responses.

Website:

www.galenea.com

Ownership Status

Out of Business

Financing Status

Corporation

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

50C Audubon Road Wakefield, MA 01880United States +1 (617) 374-1010
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Galenea's full profile, request a free trial.

    Galenea Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Galenea Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Galenea Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Mark BenjaminChief Executive Officer, Board Member & President
    David Gerber Ph.DVice President, Research & Scientific Founder
    David NeafusChief Financial Officer
    Mark Benjamin Chief Executive Officer, Board Member & President
    David Gerber Ph.D Vice President, Research & Scientific Founder
    David Neafus Chief Financial Officer

    Galenea Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Stephen Gillies Ph.DSelfBoard Member000 0000
    Stephen Heinemann Ph.DSelfBoard Member000 0000
    Susumu Tonegawa Ph.DSelfScientific Advisory Board Member000 0000
    Yasuo IrieSelfBoard Member000 0000
    Stephen Gillies Ph.D Board Member Self
    Stephen Heinemann Ph.D Board Member Self
    Susumu Tonegawa Ph.D Scientific Advisory Board Member Self
    Yasuo Irie Board Member Self
    Request full access to PitchBook